HLB Therapeutics Co.,Ltd.
115450
Peringkat dalam Saham
#18260
HLB Therapeutics Co.,Ltd. operates as a biotechnology company, focusing on the... HLB Therapeutics Co.,Ltd. operates as a biotechnology company, focusing on the creation of pharmaceutical products for both the South Korean and international markets. A significant part of its research and development initiatives includes GBT-201, a compound utilizing Thymosin beta designed to treat various eye ailments such as dry eye syndrome and neurotrophic keratopathy. Additionally, the company is advancing OKN-007 as a potential therapy for glioblastoma brain tumors. Beyond its pharmaceutical endeavors, HLB Therapeutics is also involved in the wholesale distribution of vaccines and the production of electrical and electronic components like motors, pumps, and transformers. The company, which established its roots in 2000 and is based in Seongnam, South Korea, underwent a name change in December 2021, transitioning from its former identity as G-treeBNT Co., Ltd. to its current designation.
Harga Saham
$2.02
Kapitalisasi Pasar
$190.66M
Perubahan (1 hari)
7.96%
Perubahan (1 tahun)
-1.16%
Negara
KR
Perdagangan HLB Therapeutics Co.,Ltd. (115450)
Kategori
Healthcare
Riwayat pemecahan saham untuk HLB Therapeutics Co.,Ltd. (115450)
Saham HLB Therapeutics Co.,Ltd. (simbol: 115450) telah mengalami total 0 kali pemecahan saham.
Pemecahan saham terbaru terjadi pada Oct 22, 2026.
Satu lembar saham 115450 yang dibeli sebelum Oct 22, 2026 sekarang setara dengan 0 lembar saham 115450.
Pemecahan saham terbaru terjadi pada Oct 22, 2026.
Satu lembar saham 115450 yang dibeli sebelum Oct 22, 2026 sekarang setara dengan 0 lembar saham 115450.
Daftar pemecahan saham
| Tahun | Pemecahan | Kelipatan | Kelipatan Kumulatif |
|---|---|---|---|
| Tidak cukup data untuk tanggal yang disediakan. | |||
Pemecahan saham untuk perusahaan sejenis atau pesaing
| Perusahaan | Jumlah pemecahan saham | Kelipatan Kumulatif | Negara |
|---|---|---|---|
| 1 | x2 |
US
|
|
| 0 | - |
US
|
|
| 1 | x3 |
AU
|
|
| 0 | - |
NL
|
|
| 0 | - |
CH
|
